• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Medtronic Mexico S. De R.L. De CV EVOLUT FX PLUS VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Medtronic Mexico S. De R.L. De CV EVOLUT FX PLUS VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number EVFXPLUS-34
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes Chest Pain (1776); Dyspnea (1816); Cardiac Enzyme Elevation (1838); High Blood Pressure/ Hypertension (1908); Peripheral Edema (4578)
Date of Event 07/06/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that 4 days following the implant of this transcatheter bioprosthetic aortic valve within a pre-existing medtronic transcatheter valve, the patient presented to the emergency department with non-cardiac chest pain and a hypertensive emergency.The systolic blood pressure measured in the range of 210  millimeters of mercury (mm hg) and the diastolic blood pressure was >100 mmhg.The chest pain was a short lived episode of midsternal, non-radiating chest pressure, shortness of breath, dyspnea on exertion, and mild low extremity swelling.An electrocardiogram (ecg) showed no evidence of obvious st elevations to indicate acute ischemia or infarct.Troponins were reported as ¿flat¿ which measured 45 and 41.The b-type natriuretic peptide (bnp) was minimally elevated at 149.Intravenous diuretics and a nitroglycerin drip were administered.Cardiology was consulted.Hospitalization was required and was prolonged by the hypertensive event.Discharge occurred 2 days following admission.The chest pain event was reported causal related to the transcatheter valve.The hypertensive event was reported as unrelated to the medtronic products and the implant procedure.The cause was not reported.Both events were reported as resolving.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX PLUS VALVE
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
Medtronic Mexico S. De R.L. De CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX  22210
Manufacturer (Section G)
Medtronic Mexico S. De R.L. De CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX   22210
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
+353(091)708096
MDR Report Key50069191
Report Number9617601-2026-04689
Device Sequence Number16006771
Product Code NPT
UDI-Device Identifier00763000716158
UDI-Public(01)00763000716158(17)280217(20)01
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P130021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberEVFXPLUS-34
Device Catalogue NumberEVFXPLUS-34
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/07/2026
Supplement Date Received by Manufacturer08/27/2026
Initial Report FDA Received Date07/29/2026
Supplement Report FDA Received Date09/23/2026
Date Device Manufactured02/17/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age85 YR
Patient SexMale
Patient Weight258 LB
Patient RaceWhite
-
-